http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32194775

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 288
issn 1524-4539
0009-7322
issueIdentifier 4
pageRange 281-288
publicationName Circulation
startingPage 281
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7cd8e85dd9619fd57e893b0e510a2ba3
bibliographicCitation Morrow DA, de Lemos JA, Sabatine MS, Wiviott SD, Blazing MA, Shui A, Rifai N, Califf RM, Braunwald E. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation. 2006 Jul 25;114(4):281–8. doi: 10.1161/circulationaha.106.628909. PMID: 16847150.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4e65dac790a021148855a65b937b1ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_532603bdedff942a0a58d2a67b3d2d9e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9acd45e09d7b0f9e9827476ddc15b41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe7e2b1e90ccc857db0ccbeb0177bc70
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d88885d4aba76379de060cae9c9aee1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91d7936fc05054aa1713ea09b1fef79b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7ad2c796fbb918849737bc44219dff2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7794e910d6a5d9ee3fff04a505b619b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75dd90cef4bee0c3466eddfdf0e46195
date 2006-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1161/circulationaha.106.628909
https://pubmed.ncbi.nlm.nih.gov/16847150
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2979
https://portal.issn.org/resource/ISSN/0009-7322
https://portal.issn.org/resource/ISSN/1524-4539
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial
discusses http://id.nlm.nih.gov/mesh/M0211213
http://id.nlm.nih.gov/mesh/M0022203
http://id.nlm.nih.gov/mesh/M0029425
http://id.nlm.nih.gov/mesh/M0012590
http://id.nlm.nih.gov/mesh/M0003122
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D003327Q000188
http://id.nlm.nih.gov/mesh/D014443Q000031
http://id.nlm.nih.gov/mesh/D019821Q000627
http://id.nlm.nih.gov/mesh/D002097Q000032
http://id.nlm.nih.gov/mesh/D003327Q000175
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008077Q000097
http://id.nlm.nih.gov/mesh/D000077466
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D003327Q000401
http://id.nlm.nih.gov/mesh/D005500
http://id.nlm.nih.gov/mesh/D014443Q000627
http://id.nlm.nih.gov/mesh/D000208
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D012307
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60946
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64781

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129200050

Total number of triples: 65.